arrow
S

Simona Guérzoni

Headache Center and Drug Abuse
H指数:26
被引数:2,368

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study

瑞美吉泮在多次急性偏头痛发作中的有效性:一项真实世界、前瞻性、多中心研究

2026-10-270
PRE
Migraine in Older Adults: Age‐Related Clinical Features From the Italian RICe Registry

老年人群中的偏头痛:来自意大利<scp>RICe</scp>登记研究的年龄相关临床特征

2026-10-140
OAAI
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy

在偏头痛管理中构建桥梁:意大利初级保健和专科护理最佳实践的共识路径

2026-05-190
OAAI
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability

阿托格匹兰特在偏头痛预防中的时辰药理学:关于给药时间对有效性和耐受性影响的真实世界评估

2026-03-250
PRE
The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectiveness

意大利参与者在真实世界、泛欧洲、前瞻性、观察性、IV期PEARL研究中关于fremanezumab有效性的第二次中期分析

2025-10-170
OA
No Increase in Blood Pressure Assessed With the 24-h Holter Monitoring in Patients With Episodic Migraine During Early Treatment With Anti-CGRP Monoclonal Antibodies: A Prospective Observational Study (SAFHYPER)

使用24小时动态血压监测评估的偏头痛患者在早期使用CGRP单克隆抗体治疗期间血压无增加:一项前瞻性观察研究(SAFHYPER)

2025-09-060
OAAI
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study
2024-11-260
PRE
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study
2023-11-243
OAAI
Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor

丛集性头痛全基因组关联研究和荟萃分析确定了八个基因座,并暗示吸烟是因果危险因素

2023-08-0721
OA
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study
2022-11-030
PRE
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
2022-03-1926
OAAI